Inhibition of the tyrosine kinase, Syk, analyzed by stepwise nonparametric regression

Journal of Chemical Information and Modeling

Volumn 45, Issue 3, 2005, Pages 768-776

  McNeany, T John ^a   Hirst, Jonathan D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; ENZYMES; HYDROPHOBICITY; MATHEMATICAL MODELS; MONITORING; NEURAL NETWORKS; PHARMACODYNAMICS; REGRESSION ANALYSIS; SUBSTRATES;

IMMUNORECEPTOR; KINASE; NONPARAMETRIC REGRESSION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP (QSAR);

ENZYME KINETICS;

ENZYME INHIBITOR; PROTEIN KINASE ZAP 70; PROTEIN TYROSINE KINASE;

ARTICLE; CHEMISTRY; DRUG ANTAGONISM; NONPARAMETRIC TEST; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ENZYME INHIBITORS; PROTEIN-TYROSINE KINASES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; STATISTICS, NONPARAMETRIC; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 20444425813     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci049631t     Document Type: Article

References (60)

1. Williams, D. H.; Mitchell, T. Latest developments in crystallography and structure-based design of protein kinase inhibitors as drug candidates. Curr. Opin. Pharmacol. 2002, 2, 567-573.
2. Chu, D. H.; Morita, C. T.; Weiss, A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol. Rev. 1998, 165, 167-180.
3. Turner, M.; Schweighoffer, E.; Colucci, F.; Di Santo, J. P.; Tybulewicz, V. L. Tyrosine kinase SYK: essential functions for immunoreceptor signaling. Immunol. Today 2000, 21, 148-154.
4. Niimi, T.; Orita, M.; Okazawa-Igarashi, M.; Sakashita, H.; Kikuchi, K.; Ball, E.; Ichikawa, A.; Yamagiwa, Y.; Sakamoto, S.; Tanaka, A.; Tsukamoto, S.; Fujita, S.; Tatsuta, K.; Maeda, Y.; Chikauchi, K. Design and synthesis of nonpeptidic inhibitors for the Syk C-terminal SH2 domain based on structure-based in-silico screening. J. Med. Chem. 2001, 44, 4737-4740.
5. Watson, S. P.; Gibbins, J. Collagen receptor signaling in platelets: extending the role of the ITAM. Immunol. Today 1998, 19, 260-264.
6. Hubbard, S. R. Protein tyrosine kinases: autoregulation and small-molecule inhibition. Curr. Opin. Struct. Biol. 2002, 12, 735-741.
7. Schindler, T.; Bornmann, W.; Pellicena, P.; Miller, W. T.; Clarkson, B.; Kuriyan, J. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science 2000, 289, 1938-1942.
8. Pargellis, C.; Tong, L.; Churchill, L.; Cirillo, P. F.; Gilmore, T.; Graham, A. G.; Grob, P. M.; Hickey, E. R.; Moss, N.; Pav, S.; Regan, J. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat. Struct. Biol. 2002, 9, 268-272.
9. Shen, M.; Beguin, C.; Golbraikh, A.; Stables, J. P.; Kohn, H.; Tropsha, A. Application of predictive QSAR models to database mining: Identification and experimental validation of novel anticonvulsant compounds. J. Med. Chem. 2004, 47, 2356-2364.
10. Macchiarulo, A.; De Luca, L.; Costantino, G.; Barreca, M. L.; Gitto, R.; Pellicciari, R.; Chimirri, A. QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor. J. Med. Chem. 2004, 47, 1860-1863.
11. Lapinsh, M.; Prusis, P.; Mutule, I.; Mutulis, F.; Wikberg, J. E. S. QSAR and proteo-chemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes. J. Med. Chem. 2003, 46, 2572-2579.
12. Shen, M.; Xiao, Y. D.; Golbraikh, A.; Gombar, V. K.; Tropsha, A. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. J. Med. Chem. 2003, 46, 3013-3020.
13. Austin, R. P.; Barton, P.; Bonnert, R. V.; Brown, R. C.; Cage, P. A.; Cheshire, D. R.; Davis, A. M.; Dougall, I. G.; Ince, F.; Pairaudeau, G.; Young, A. QSAR and the rational design of long-acting dual D-2-receptor/beta(2)- adrenoceptor agonists. J. Med. Chem. 2003, 46, 3210-3220.
14. Topliss, J. G.; Edwards, R. Chance Factors in Studies of Quantitative Structure-Activity Relationships. J. Med. Chem. 1979, 22, 1238-1244.
15. Lucie, B.; Nadramija, D.; Basic, I.; Trinajstic, N. Toward generating simpler QSAR models: Nonlinear multivariate regression versus several neural network ensembles and some related methods. J. Chem. Inf. Comput. Sci. 2003, 43, 1094-1102.
16. Draper, N. R.; Smith, H. Applied Regression Analysis, 3rd ed.; Wiley: New York, 1998.
17. Hirst, J. D. Nonlinear quantitative structure-activity relationship for the inhibition of dihydrofolate reductase by pyrimidines. J. Med. Chem. 1996, 39, 3526-3532.
18. Constans, P.; Hirst, J. D. Nonparametric regression applied to quantitative structure-activity relationships. J. Chem. Inf. Comput. Sci. 2000, 40, 452-459.
19. Hirst, J. D.; McNeany, T. J.; Howe, T.; Whitehead, L. Application of nonparametric regression to quantitative structure-activity relationships. Bioorg. Med. Chem. 2002, 10, 1037-1041.
20. Chemometric Methods in Drug Design; van der Waterbeemd, H., Ed.; VCH: Weinheim, 1995.
21. Hirst, J. D.; King, R. D.; Sternberg, M. J. E. Quantitative Structure-Activity-Relationships by Neural Networks and Inductive Logic Programming. 1. The Inhibition of Dihydrofolate-Reductase by Pyrimidines. J. Comput.-Aided Mol. Des. 1994, 8, 405-420.
22. Aoyama, T.; Ichikawa, H. Neural Networks as Nonlinear Structure Activity Relationship Analyzers - Useful Functions of the Partial Derivative Method in Multilayer Neural Networks. J. Chem. Inf. Comput. Sci. 1992, 32, 492-500.
23. Niculescu, S. P. Artificial neural networks and genetic algorithms in QSAR. Theochem-J. Mol. Struct. 2003, 622, 71-83.
24. So, S. S.; Richards, W. G. Application of Neural Networks - Quantitative Structure-Activity-Relationships of the Derivatives of 2,4-Diamino-5- (Substituted-Benzyl)Pyrimidines as Dhfr Inhibitors. J. Med. Chem. 1992, 35, 3201-3207.
25. Harper, G.; Bradshaw, J.; Gittins, J. C.; Green, D. V. S.; Leach, A. R. Prediction of biological activity for high-throughput screening using binary kernel discrimination. J. Chem. Inf. Comput. Sci. 2001, 41, 1295-1300.
26. Liu, H. X.; Zhang, R. S.; Yao, X. J.; Liu, M. C.; Hu, Z. D.; Fan, B. T. QSAR study of ethyl 2-(3-methyl-2,5-dioxo(3-pyrrolinyl))amino -4-(trifluoromethyl) pyrimidine-5-carboxylate: An inhibitor of AP-I and NF-kappa B mediated gene expression based on support vector machines. J. Chem. Inf. Comput. Sci. 2003, 43, 1288-1296.
27. Zernov, V. V.; Balakin, K. V.; Ivaschenko, A. A.; Savchuk, N. P.; Pletnev, I. V. Drug discovery using support vector machines. The case studies of drug-likeness, agrochemical-likeness, and enzyme inhibition predictions. J. Chem. Inf. Comput. Sci. 2003, 43, 2048-2056.
28. NguyenCong, V.; VanDang, G.; Rode, B. M. Using multivariate adaptive regression splines to QSAR studies of dihydroartemisinin derivatives. Eur. J. Med. Chem. 1996, 31, 797-803.
29. Ren, S. J.; Kim, H. Comparative assessment of multiresponse regression methods for predicting the mechanisms of toxic action of phenols. J. Chem. Inf. Comput. Sci. 2003, 43, 2106-2110.
30. Ren, S. J. Modeling the toxicity of aromatic compounds to Tetrahymena pyriformis: The response surface methodology with nonlinear methods. J. Chem. Inf. Comput. Sci. 2003, 43, 1679-1687.
31. Lahsen, J.; Schmidhammer, H.; Rode, B. M. Structure-activity relationship study of nonpeptide delta- opioid receptor ligands. Helv. Chim. Acta 2001, 84, 3299-3305.
32. Sutter, J. M.; Dixon, S. L.; Jurs, P. C. Automated Descriptor Selection for Quantitative Structure-Activity-Relationships Using Generalized Simulated Annealing. J. Chem. Inf. Comput. Sci. 1995, 35, 77-84.
33. Cho, S. J.; Hermsmeier, M. A. Genetic algorithm guided selection: Variable selection and subset selection. J. Chem. Inf. Comput. Sci. 2002, 42, 927-936.
34. Nicolotti, O.; Gillet, V. J.; Fleming, P. J.; Green, D. V. S. Multiobjective optimization in quantitative structure-activity relationships: Deriving accurate and interpretable QSARs. J. Med. Chem. 2002, 45, 5069-5080.
35. Agrafiotis, D. K.; Cedeno, W. Feature selection for structure-activity correlation using binary particle swarms. J. Med. Chem. 2002, 45, 1098-1107.
36. Kirkpatrick, S.; Gelatt, C. D.; Vecchi, M. P. Optimization by Simulated Annealing. Science 1983, 220, 671-680.
37. Metropolis, N.; Rosenbluth, A. W.; Teller, A. H.; Rosenbluth, M. N.; Teller, E. Equation of State Calculations by Fast Computing Machines. J. Chem. Phys. 1953, 21, 1087-1092.
38. Goldberg, D. E. Genetic Algorithms in Search, Optimization, and Machine Learning; Addison-Wesley: New York, 1989.
39. Collingwood, P. S.; Hayler, J.; LeGrand, D. M.; Mattes, H.; Menear, K. A.; Walker, C. V.; Cockroft, X.-L. Purine Derivatives Inhibitors of Tyrosine Protein Kinase Syk; Novartis AG, Basel: United States, 2003.
40. Cerius2; Molecular Simulations Inc.: San Diego, CA.
41. Nadaraya, E. A. On Estimating Regression. Theory of Probability and Its Applications; 1964; Vol. 10, pp 186-190.
42. Watson, G. S. Smooth regression analysis. Sankya-The Indian J. Statistics Ser. A 1964, 26, 359-372.
43. Hardie, W.; Marron, J. S. Fast and Simple Scatterplot Smoothing. Computational Statistics Data Analysis 1995, 20, 1-17.
44. Mammen, E.; Marron, J. S. Mass recentered kernel smoothers. Biometrika 1997, 84, 765-777.
45. Stone, C. J. Consistent Non-Parametric Regression. Ann. Stat. 1977, 5, 595.
46. Hastie, T. J.; Tibshirani, R. J. Generalized Additive Models; Chapman and Hall: New York, 1990.
47. Buja, A.; Hastie, T.; Tibshirani, R. Linear Smoothers and Additive-Models. Ann. Stat. 1989, 17, 453-510.
48. Churchwell, C. J.; Rintoul, M. D.; Martin, S.; Visco, D. P.; Kotu, A.; Larson, R. S.; Sillerud, L. O.; Brown, D. C.; Faulon, J. L. The signature molecular descriptor -3. Inverse-quantitative structure - activity relationship of ICAM-1 inhibitory peptides. J. Mol. Graph. 2004, 22, 263-273.
49. Xue, C. X.; Zhang, R. S.; Liu, H. X.; Yao, X. J.; Liu, M. C.; Hu, Z. D.; Fan, B. T. An accurate QSPR study of O-H bond dissociation energy in substituted phenols based on support vector machines. J. Chem. Inf. Comput. Sci. 2004, 44, 669-677.
50. Roy, K.; Leonard, J. T. QSAR modeling of HIV-1 reverse transcriptase inhibitor 2-amino- 6-arylsulfonylbenzonitriles and congeners using molecular connectivity and E-state parameters. Bioorg. Med. Chem. 2004, 12, 745-754.
51. Netzeva, T. I.; Dearden, J. C.; Edwards, R.; Worgan, A. D. P.; Cronin, M. T. D. QSAR analysis of the toxicity of aromatic compounds to Chlorella vulgaris in a novel short-term assay. J. Chem. Inf. Comput. Sci. 2004, 44, 258-265.
52. Moon, T.; Song, J. S.; Lee, J. K.; Yoon, C. N. QSAR analysis of SH2-binding phosphopeptides: Using interaction energies and cross-correlation coefficients. J. Chem. Inf. Comput. Sci. 2003, 43, 1570-1575.
53. Hawkins, D. M.; Basak, S. C.; Mills, D. Assessing model fit by cross-validation. J. Chem. Inf. Comput. Sci. 2003, 43, 579-586.
54. Kennard, R. W.; Stone, L. A. Computer Aided Design of Experiments. Technometrics 1969, 11, 137-148.
55. Faber, N. K. M. Estimating the uncertainty in estimates of root-mean-square error of prediction: application to determining the size of an adequate test set in multivariate calibration. Chemom. Intell. Lab. Syst. 1999, 49, 79-89.
56. Ghose, A. K.; Viswanadhan, V. N.; Wendoloski, J. J. Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: An analysis of ALOGP and CLOGP methods. J. Phys. Chem. A 1998, 102, 3762-3772.
57. Kier, L. B.; Hall, L. H. Molecular Connectivity in Structure-Activity Analysis; John Wiley & Sons: New York, 1986.
58. Hall, L. H.; Kier, L. B. The Kappa Indices for Modeling Molecular Shape and Flexibility. Topological Indices and Related Descriptors in QSAR and QSPR; Gordon and Breach: Reading U.K., 1999; pp 307-360.
59. Fahlman, S. E.; Lebiere, C. The Cascade-Correlation Learning Architecture. Advances in Neural Information Processing Systems; Kaufmann Publishers: 1990; pp 524-532.
60. Witten, I. H.; Frank, E. Data Mining: Practical Machine Learning Tools and Techniques with Java Applications; Morgan Kaufmann: San Francisco, 1999.